Occurrence of perfluorinated alkylated substances in breast milk of French women and relation with socio-demographical and clinical parameters: Results of the ELFE pilot study

Chemosphere

Volumn 91, Issue 6, 2013, Pages 802-808

  Antignac, Jean Philippe ^a,b   Veyrand, Bruno ^a   Kadar, Hanane ^a   Marchand, Philippe ^a   Oleko, Amivi ^c   Bizec, Bruno Le ^a   Vandentorren, Stéphanie ^c  

^a UNIVERSITÉ DE NANTES   (France)

^b CEMAGREF   (France)

^c INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

Breast milk; Endocrine disruption; Perfluorinated alkylated substances; Perinatal exposure

Indexed keywords

LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

BREAST MILK; CONCENTRATION LEVELS; EMERGING CONTAMINANT; ENDOCRINE DISRUPTION; HIGH RESOLUTION MASS SPECTROMETRY; PERFLUORINATED ALKYLATED SUBSTANCES; PERFLUOROALKYLATED SUBSTANCES; PERINATAL EXPOSURE;

POPULATION STATISTICS;

ALCOHOL; ENDOCRINE DISRUPTOR; PERFLUORINATED ALKYLATED SUBSTANCE; PERFLUOROOCTANE SULFONYL FLUORIDE; PERFLUOROOCTANESULFONIC ACID; POLITEF; UNCLASSIFIED DRUG;

CONCENTRATION (COMPOSITION); DATA SET; DETECTION METHOD; ENDOCRINE DISRUPTOR; ORGANIC ACID; PARAMETERIZATION; POLLUTION EFFECT; POLLUTION EXPOSURE; WOMENS HEALTH;

ALKYLATION; ARTICLE; BIRTH WEIGHT; BREAST MILK; CONTROLLED STUDY; DEMOGRAPHY; FLUORINATION; FOOD CONTAMINATION; FOOD INTAKE; FRANCE; HUMAN; LIMIT OF DETECTION; MEDICAL RESEARCH; MILK; PILOT STUDY; PUBLICATION; SEA FOOD; SMOKING; SOCIOECONOMICS;

FRANCE;

EID: 84875662804     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2013.01.088     Document Type: Article

References (40)

1. Ahrens L. Polyfluoroalkyl compounds in the aquatic environment: a review of their occurrence and fate. J. Environ. Monit. 2011, 13(1):20-31.
2. Benskin J.P., De Silva A.O., Martin J.W. Isomer profiling of perfluorinated substances as a tool for source tracking: a review of early findings and future applications. Rev. Environ. Contam. Toxicol. 2010, 208:111-160.
3. Bernsmann T., Fürst P. Determination of perfluorinated compounds in human milk. Organohalogen Compd. 2008, 70:718-721.
4. Conder J.M., Hoke R.A., De Wolf W., Russell M.H., Buck R.C. Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds. Environ. Sci. Technol. 2008, 42(4):995-1003.
5. Das K.P., Grey B.E., Zehr R.D., Wood C.R., Butenhoff J.L., Chang S.C., et al. Effects of perfluorobutyrate exposure during pregnancy in the mouse. Toxicol. Sci. 2008, 105(1):173-181.
6. D'Hollander W., de Voogt P., De Coen W., Bervoets L. Perfluorinated substances in human food and other sources of human exposure. Rev. Environ. Contam. Toxicol. 2010, 208:179-215.
7. Fromel T., Knepper T.P. Biodegradation of fluorinated alkyl substances. Rev. Environ. Contam. Toxicol. 2010, 208:161-177.
8. Fromme H., Tittlemier S.A., Volkel W., Wilhelm M., Twardella D. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int. J. Hyg. Environ. Health 2009, 212(3):239-270.
9. Fujii Y., Yan J., Harada K.H., Hitomi T., Yang H., Wang P., et al. Levels and profiles of long-chain perfluorinated carboxylic acids in human breast milk and infant formulas in East Asia. Chemosphere 2012, 86(3):315-321.
10. Haug L.S., Huber S., Becher G., Thomsen C. Characterisation of human exposure pathways to perfluorinated compounds-comparing exposure estimates with biomarkers of exposure. Environ. Int. 2011, 37(4):687-693.
11. Jensen A.A., Leffers H. Emerging endocrine disrupters: perfluoroalkylated substances. Int. J. Androl. 2008, 31(2):161-169.
12. Johansson N., Eriksson P., Viberg H. Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain. Toxicol. Sci. 2009, 108(2):412-418.
13. Kadar H., Veyrand B., Barbarossa A., Legrand A., Boquien C.Y., Durand S., Monteau F., Le Bizec B., Antignac J.P. Development of an analytical strategy based on liquid chromatography - high resolution mass spectrometry for measuring perfluorinated compounds in human breast milk: application to the generation of preliminary data regarding perinatal exposure in France. Chemosphere 2011, 85(3):473-480.
14. Karrman A., Ericson I., van Bavel B., Darnerud P.O., Aune M., Glynn A., et al. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004 Sweden. Environ. Health. Perspect. 2007, 115(2):226-230.
15. Karrman A., Domingo J.L., Llebaria X., Nadal M., Bigas E., van Bavel B., et al. Biomonitoring perfluorinated compounds in Catalonia, Spain: concentrations and trends in human liver and milk samples. Environ. Sci. Pollut. Res. Int. 2010, 17(3):750-758.
16. Kennedy G.L., Butenhoff J.L., Olsen G.W., O'Connor J.C., Seacat A.M., Perkins R.G., et al. The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 2004, 34(4):351-384.
17. Kim S.K., Lee K.T., Kang C.S., Tao L., Kannan K., Kim K.R., et al. Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures. Environ. Pollut. 2011, 159(1):169-174.
18. Kim S., Choi K., Ji K., Seo J., Kho Y., Park J., et al. Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. Environ. Sci. Technol. 2011, 45(17):7465-7472.
19. Lau C., Butenhoff J.L., Rogers J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol. Appl. Pharmacol. 2004, 198(2):231-241.
20. Lehmler H.J. Synthesis of environmentally relevant fluorinated surfactants-a review. Chemosphere 2005, 58(11):1471-1496.
21. Lewandowski G., Meissner E., Milchert E. Special applications of fluorinated organic compounds. J. Hazard. Mater. 2006, 136(3):385-391.
22. Liu J., Li J., Liu Y., Chan H.M., Zhao Y., Cai Z., et al. Comparison on gestation and lactation exposure of perfluorinated compounds for newborns. Environ Int. 2011, 37(7):1206-1212.
23. Liu J., Li J., Zhao Y., Wang Y., Zhang L., Wu Y. The occurrence of perfluorinated alkyl compounds in human milk from different regions of China. Environ Int. 2010, 36(5):433-438.
24. Liu X., Liu W., Jin Y., Yu W., Wang F., Liu L. Effect of gestational and lactational exposure to perfluorooctanesulfonate on calcium-dependent signaling molecules gene expression in rats' hippocampus. Arch. Toxicol. 2010, 84(1):71-79.
25. Llorca M., Farre M., Pico Y., Teijon M.L., Alvarez J.G., Barcelo D. Infant exposure of perfluorinated compounds: Levels in breast milk and commercial baby food. Environ Int. 2010, 36(6):584-592.
26. Luebker D.J., York R.G., Hansen K.J., Moore J.A., Butenhoff J.L. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology 2005, 215(1-2):149-169.
27. Nakata A., Katsumata T., Iwasaki Y., Ito R., Saito K., Izumi S., Makino T., Kishi R., Nakazawa H. Measurement of perfluorinated compounds in human milk and house dust. Organohalogen Compd. 2007, 69:2844-2846.
28. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 2007, 115(9):1298-1305.
29. Olsen G.W., Butenhoff J.L., Zobel L.R. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod. Toxicol. 2009, 27(3-4):212-230.
30. Rayne S., Forest K. Perfluoroalkyl sulfonic and carboxylic acids: a critical review of physicochemical properties, levels and patterns in waters and wastewaters, and treatment methods. Environ. Sci. Health, Part A: Toxic/Hazard. Subst. Environ. Eng. 2009, 44(12):1145-1199.
31. Roosens L., D'Hollander W., Bervoets L., Reynders H., Van Campenhout K., Cornelis C., et al. Brominated flame retardants and perfluorinated chemicals, two groups of persistent contaminants in Belgian human blood and milk. Environ. Pollut. 2010, 158(8):2546-2552.
32. So M.K., Yamashita N., Taniyasu S., Jiang Q., Giesy J.P., Chen K., et al. Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan. China. Environ. Sci. Technol. 2006, 40(9):2924-2929.
33. Steenland K., Fletcher T., Savitz D.A. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ. Health. Perspect. 2010, 118(8):1100-1108.
34. Tao L., Ma J., Kunisue T., Libelo E.L., Tanabe S., Kannan K. Perfluorinated compounds in human breast milk from several Asian countries, and in infant formula and dairy milk from the United States. Environ. Sci. Technol. 2008, 42(22):8597-8602.
35. Vestergren R., Cousins I.T. Tracking the pathways of human exposure to perfluorocarboxylates. Environ. Sci. Technol. 2009, 43(15):5565-5575.
36. Volkel W., Genzel-Boroviczeny O., Demmelmair H., Gebauer C., Koletzko B., Twardella D., et al. Perfluorooctane sulphonate (PFOS) and perfluorooctanoic acid (PFOA) in human breast milk: results of a pilot study. Int. J. Hyg. Environ. Health 2008, 211(3-4):440-446.
37. Wang T., Wang Y., Liao C., Cai Y., Jiang G. Perspectives on the inclusion of perfluorooctane sulfonate into the stockholm convention on persistent organic pollutants. Environ. Sci. Technol. 2009, 43:5171-5175.
38. White S.S., Calafat A.M., Kuklenyik Z., Villanueva L., Zehr R.D., Helfant L., et al. Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol. Sci. 2007, 96(1):133-144.
39. White S.S., Fenton S.E., Hines E.P. Endocrine disrupting properties of perfluorooctanoic acid. J. Steroid. Biochem. Mol. Biol. 2011, 127(1-2):16-26.
40. Yahia D., El-Nasser M.A., Abedel-Latif M., Tsukuba C., Yoshida M., Sato I., et al. Effects of perfluorooctanoic acid (PFOA) exposure to pregnant mice on reproduction. J. Toxicol. Sci. 2010, 35(4):527-533.